Lotus Pharmaceuticals (LTUS) Stock Statistics & Valuation Metrics
Total Valuation
Lotus Pharmaceuticals has a market cap or net worth of $112.66K. The enterprise value is $109.75B.
- Market Cap
- $112.66K
- Enterprise Value
- $109.75B
Share Statistics
Lotus Pharmaceuticals has 27,816,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 27,816,000
- Owned by Insiders
- ―
- Owned by Institutions
- 0.14%
Financial Efficiency
Lotus Pharmaceuticals’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is -331.10%.
- Return on Equity (ROE)
- 0.17
- Return on Assets (ROA)
- -3.31
- Return on Invested Capital (ROIC)
- -331.10%
- Return on Capital Employed (ROCE)
- 0.17
- Revenue Per Employee
- 0
- Profits Per Employee
- -80.738
- Employee Count
- 233
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Lotus Pharmaceuticals is -355.29. Lotus Pharmaceuticals’s PEG ratio is -3.55.
- PE Ratio
- -355.29
- PS Ratio
- 0.00
- PB Ratio
- 0.00
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -3.55
Income Statement
In the last 12 months, Lotus Pharmaceuticals had revenue of 0 and earned -18.81K in profits. Earnings per share was 0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -18.81K
- Pretax Income
- -18.81K
- Net Income
- -18.81K
- EBITDA
- -18.81K
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was -16.40K and capital expenditures 0, giving a free cash flow of -16.40K billion.
- Operating Cash Flow
- -16.40K
- Free Cash Flow
- -16.40K
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Lotus Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- -0.28%
Stock Price Statistics
- Beta
- -2.16
- 52-Week Price Change
- ―
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Lotus Pharmaceuticals as a current ratio of 0.05, with Debt / Equity ratio of -105.12%
- Current Ratio
- 0.05
- Quick Ratio
- 0.05
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -6.10
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Lotus Pharmaceuticals has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Lotus Pharmaceuticals EV to EBITDA ratio is -3.74, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.00
- EV to EBITDA
- -3.74
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Lotus Pharmaceuticals has $419.00 in cash and marketable securities with $123.43K in debt, giving a net cash position of -$123.01K billion.
- Cash & Marketable Securities
- $419.00
- Total Debt
- $123.43K
- Net Cash
- -$123.01K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Lotus Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
